Glimtino MP 2mg/500mg/15mg Tablet SR
Marketer
Biovensia Pharmaceutical
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glimtino MP 2mg/500mg/15mg Tablet SR
Metformin-Glimepiride-Pioglitazone extended-release tablets (2mg/500mg/15mg) are a triple-combination medication managing blood glucose. This therapy, alongside diet and exercise, improves glycemic control in adult type 2 diabetics. It enhances insulin effectiveness, thus reducing blood sugar. Dosage and duration for Metformin-Glimepiride-Pioglitazone should strictly adhere to your physician's instructions. Administer with food to minimize gastric discomfort. Missed doses should be taken promptly unless nearing the next scheduled dose; in that case, omit the missed dose and resume the regular regimen. Never double the dose. Overdosage can cause dangerously low blood sugar (hypoglycemia). Concomitant use with other antidiabetic agents, alcohol consumption, or skipped meals may trigger hypoglycemia. Regular blood glucose monitoring is crucial. Common adverse effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or cardiac issues to your doctor. Pregnant or lactating individuals must seek medical counsel before use. Renal function tests will be assessed before treatment initiation. Limit alcohol consumption to reduce the risk of side effects.
Uses of Glimtino MP 2mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Glimtino MP 2mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimtino MP 2mg/500mg/15mg Tablet SR whole; do not damage the tablet by chewing, crushing, or breaking it. Administer this medicine with food.
Common Side effects of Glimtino MP 2mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimtino MP 2mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimtino MP 2mg/500mg/15mg Tablet SR whole; do not alter its form by chewing, crushing, or breaking. Administer this medication with a meal.
How Glimtino MP 2mg/500mg/15mg Tablet SR works:
Glimtino MP 2mg/500mg/15mg Extended-Release tablets combine three distinct antidiabetic agents: glimepiride, metformin, and pioglitazone. This triple-action approach improves blood glucose management when single or dual drug regimens prove inadequate. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts through multiple pathways: reducing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further amplifies the body's insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimtino MP 2mg/500mg/15mg SR tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The extended-release Glimtino MP 2mg/500mg/15mg tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Consult your physician for guidance.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Glimtino MP tablets (2mg/500mg/15mg) are likely not safe for breastfeeding mothers. Available human data indicates potential drug transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Impaired driving is possible with severely high or low blood glucose levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Exercise caution when administering Glimtino MP 2mg/500mg/15mg SR tablets to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. The use of Glimtino MP 2mg/500mg/15mg SR tablets is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of kidney function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glimtino MP 2mg/500mg/15mg Tablet SR cautiously, potentially requiring dosage modification. Physician consultation is advised. Glimtino MP 2mg/500mg/15mg Tablet SR is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Glimtino MP 2mg/500mg/15mg Tablet SR :
Should you forget a dose of Glimtino MP 2mg/500mg/15mg Tablet SR, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.
Facts to Know About Glimtino MP 2mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Type of Medication | Medication for diabetes |
3,018 People bought this recently